Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.6 USD | -0.04% | +1.26% | +0.47% |
04-18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
04-18 | Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.47% | 7.73B | |
-1.65% | 103B | |
+6.75% | 101B | |
+7.13% | 23.07B | |
-12.60% | 22.23B | |
-7.05% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- Goldman Sachs Adjusts Cerevel Therapeutics Holdings' Price Target to $20 from $28, Keeps Neutral Rating